INmune Bio stock plummets after mixed Phase 2 Alzheimer’s trial results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. HPE
7. VRTS
8. AVGO
9. SNOW
10. SPY

Go back to INmune Bio stock plummets after mixed Phase 2 Alzheimer’s trial results
(NASDAQ: INMB) Delayed: 2.35 --0 (-0%)
Previous Close $2.35    52 Week High $ 
Open $2.35    52 Week Low $ 
Day High $2.35    P/E N/A 
Day Low $2.35    EPS $ 
Volume 416